Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Mylan Overcomes Biogen Bid For Tecfidera Injunction
Generics Firm Is Facing Appeal Over 2028-Expiring Patent Win
Aug 03 2020
•
By
Dean Rudge
Mylan may introduce generic Tecfidera at-risk before the year end • Source: Shutterstock
More from Legal & IP
More from Generics Bulletin
